Pharmaceutical

Accenture invests in Earli to advance early cancer detection tech

Accenture has made an investment in biotechnology company Earli for advancing early cancer detection technologies.

Aug 21, 2024 - 04:00
Accenture invests in Earli to advance early cancer detection tech
Accenture has made an investment in biotechnology company Earli for advancing early cancer detection technologies.
Read the original article

Tags:

Previous Article

GLP-1R market: a two-horse race

Next Article

Liquidia’s YUTREPIA inhalation powder gains tentative FDA approval

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Intellia propels into 2024 with CRISPR pipeline updates

Intellia propels into 2024 with CRISPR pipeline updates

Jan 5, 2024

FDA grants orphan drug status to Ionis’ olezarsen for FCS treatment

FDA grants orphan drug status to Ionis’ olezarsen for F...

Feb 16, 2024

Tonix to acquire Upsher-Smith’s migraine products

Tonix to acquire Upsher-Smith’s migraine products

Jun 27, 2023